167 related articles for article (PubMed ID: 24184602)
1. Prognostic factors and outcomes in endometrial stromal sarcoma with the 2009 FIGO staging system: a multicenter review of 114 cases.
Yoon A; Park JY; Park JY; Lee YY; Kim TJ; Choi CH; Bae DS; Kim BG; Lee JW; Nam JH
Gynecol Oncol; 2014 Jan; 132(1):70-5. PubMed ID: 24184602
[TBL] [Abstract][Full Text] [Related]
2. Ovarian preservation in stage I low-grade endometrial stromal sarcomas.
Li AJ; Giuntoli RL; Drake R; Byun SY; Rojas F; Barbuto D; Klipfel N; Edmonds P; Miller DS; Karlan BY
Obstet Gynecol; 2005 Dec; 106(6):1304-8. PubMed ID: 16319256
[TBL] [Abstract][Full Text] [Related]
3. Outcome and prognostic factors in endometrial stromal tumors: a Rare Cancer Network study.
Schick U; Bolukbasi Y; Thariat J; Abdah-Bortnyak R; Kuten A; Igdem S; Caglar H; Ozsaran Z; Lössl K; Schleicher U; Zwahlen D; Villette S; Vees H
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):e757-63. PubMed ID: 22300565
[TBL] [Abstract][Full Text] [Related]
4. Stage IA vs. IB endometrial stromal sarcoma: does the new staging system predict survival?
Garg G; Shah JP; Toy EP; Bryant CS; Kumar S; Morris RT
Gynecol Oncol; 2010 Jul; 118(1):8-13. PubMed ID: 20447684
[TBL] [Abstract][Full Text] [Related]
5. Endometrial stromal sarcoma-A retropsective analysis of factors affecting recurrence.
Agarwal R; Rajanbabu A; Nair IR; Satish C; Jose G; Unikrishnan UG
Eur J Obstet Gynecol Reprod Biol; 2017 Sep; 216():92-97. PubMed ID: 28738297
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors and outcome in women with uterine sarcoma.
Denschlag D; Masoud I; Stanimir G; Gilbert L
Eur J Surg Oncol; 2007 Feb; 33(1):91-5. PubMed ID: 17174517
[TBL] [Abstract][Full Text] [Related]
7. [Clinical review of 97 patients with endometrial stromal sarcoma].
Li N; Wu LY; Zhang HT; An JS; Li XG; Ma SK
Zhonghua Fu Chan Ke Za Zhi; 2008 Feb; 43(2):115-9. PubMed ID: 18683750
[TBL] [Abstract][Full Text] [Related]
8. Ovary and uterus-sparing procedures for low-grade endometrial stromal sarcoma: a retrospective study of 153 cases.
Bai H; Yang J; Cao D; Huang H; Xiang Y; Wu M; Cui Q; Chen J; Lang J; Shen K
Gynecol Oncol; 2014 Mar; 132(3):654-60. PubMed ID: 24412112
[TBL] [Abstract][Full Text] [Related]
9. Endometrial stromal sarcoma: a population-based analysis.
Chan JK; Kawar NM; Shin JY; Osann K; Chen LM; Powell CB; Kapp DS
Br J Cancer; 2008 Oct; 99(8):1210-5. PubMed ID: 18813312
[TBL] [Abstract][Full Text] [Related]
10. Prognostic parameters in endometrial stromal sarcoma: a clinicopathologic study in 31 patients.
Bodner K; Bodner-Adler B; Obermair A; Windbichler G; Petru E; Mayerhofer S; Czerwenka K; Leodolter S; Kainz C; Mayerhofer K
Gynecol Oncol; 2001 May; 81(2):160-5. PubMed ID: 11330943
[TBL] [Abstract][Full Text] [Related]
11. Surgery and adjuvant radiation therapy of endometrial stromal sarcoma.
Weitmann HD; Kucera H; Knocke TH; Pötter R
Wien Klin Wochenschr; 2002 Jan; 114(1-2):44-9. PubMed ID: 12407935
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of the diagnostic criteria distinguishing endometrial stromal sarcoma, low grade from undifferentiated endometrial sarcoma, 2 entities within the invasive endometrial stromal neoplasia family.
Feng W; Malpica A; Robboy SJ; Gudlaugsson E; Hua K; Zhou X; Baak JP
Int J Gynecol Pathol; 2013 May; 32(3):299-306. PubMed ID: 23545579
[TBL] [Abstract][Full Text] [Related]
13. Prognostic indicators in WHO 2003 low-grade endometrial stromal sarcoma.
Feng W; Hua K; Gudlaugsson E; Yu Y; Zhou X; Baak JP
Histopathology; 2013 Apr; 62(5):675-87. PubMed ID: 23425310
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic parameters and immunohistochemical study of endometrial stromal sarcomas.
Wu TI; Chou HH; Yeh CJ; Hsueh S; Yang JE; Jao MS; Chang TC; Hsu CS; Lin KH; Lai CH
Int J Gynecol Pathol; 2013 Sep; 32(5):482-92. PubMed ID: 23896713
[TBL] [Abstract][Full Text] [Related]
15. Low-grade and high-grade endometrial stromal sarcoma: A National Cancer Database study.
Seagle BL; Shilpi A; Buchanan S; Goodman C; Shahabi S
Gynecol Oncol; 2017 Aug; 146(2):254-262. PubMed ID: 28596015
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of steroid receptor positivity and adjuvant progestogen use in endometrial stromal sarcoma.
Cade TJ; Quinn MA; Rome RM; Polyakov A
Aust N Z J Obstet Gynaecol; 2014 Oct; 54(5):453-6. PubMed ID: 25287561
[TBL] [Abstract][Full Text] [Related]
17. Endometrial stromal sarcoma: analysis of treatment failures and survival.
Gadducci A; Sartori E; Landoni F; Zola P; Maggino T; Urgesi A; Lissoni A; Losa G; Fanucchi A
Gynecol Oncol; 1996 Nov; 63(2):247-53. PubMed ID: 8910635
[TBL] [Abstract][Full Text] [Related]
18. Survival outcomes and prognostic factors of endometrial stromal sarcoma and undifferentiated uterine sarcoma.
Cabrera S; Bebia V; Acosta U; Franco-Camps S; Mañalich L; García-Jiménez A; Gil-Moreno A
Clin Transl Oncol; 2021 Jun; 23(6):1210-1219. PubMed ID: 33210235
[TBL] [Abstract][Full Text] [Related]
19. Does radiotherapy or lymphadenectomy improve survival in endometrial stromal sarcoma?
Barney B; Tward JD; Skidmore T; Gaffney DK
Int J Gynecol Cancer; 2009 Oct; 19(7):1232-8. PubMed ID: 19823060
[TBL] [Abstract][Full Text] [Related]
20. The prognostic significance of age in surgically staged patients with Type II endometrial carcinoma.
Vance S; Yechieli R; Cogan C; Hanna R; Munkarah A; Elshaikh MA
Gynecol Oncol; 2012 Jul; 126(1):16-9. PubMed ID: 22507535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
